Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome

Pediatric Nephrology

Volumn 5, Issue 5, 1991, Pages 587-590

  Milliner, D S ^a   Morgenstern, B Z ^a  

^a MAYO CLINIC   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Nephrotic syndrome; Proteinuria; Renal function

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENALAPRIL; PREDNISONE;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESISTANCE; HUMAN; KIDNEY FUNCTION; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PROTEINS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CREATININE; DRUG RESISTANCE; HUMAN; INFANT; NEPHROTIC SYNDROME; PREDNISONE; PROTEINURIA; SERUM ALBUMIN;

EID: 0025837527     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/BF00856646     Document Type: Article

References (32)

1. Extrarenal complications of the nephrotic syndrome
2. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis
3. Focal glomerulosclerosis: natural history and treatment: a report of 70 cases
4. The prognosis of focal segmental glomerular sclerosis of adulthood
5. Renal effects of ibuprofen, priroxicam, and sulindac in patients with asymptomatic renal failure
6. Progression of chronic renal failure in man
7. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency
8. Effects of enalapril on urinary protein excretion of essential and renal parenchymal hypertensive patients
9. Effect of captopril on heavy proteinuria in azotemic diabetics
10. Captopril and proteinuria in diabetes mellitus
11. Antiproteinuric effect of captopril in primary glomerular disease
12. Angiotensin converting enzyme inhibitors and progressive renal insufficiency
13. Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease
14. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine
15. Glomerular filtration rate and renal plasma flow
16. Therapeutic implications of converting-enzyme inhibitors in renal disease
17. Angiotenin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat
18. Reduction of proteinuria by angiotensin converting enzyme inhibition
19. Mechanisms underlying transition from acute glomerular injury to glomerulosclerosis in a rat model of nephrotic syndrome
20. Reversing glomerular hypertension stabilizes established glomerular injury
21. Role for angiotensin-II in overt proteinuria
22. Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules
23. Tubular transport responses to angiotensin
24. Angiotensin II. A potent regulator of acidification in the rat early proximal convoluted tubule
25. In situ hybridization evidence for antiotensinogen messenger RNA in the rat proximal tubule
26. Immunocytochemistry of the renin angiotensin system: renin, angiotensinogen, angiotensin I, angiotensin II, and converting enzyme in the kidneys of mice, rats, and tree shrews
27. Renal angiotensin converting enzyme (ACE) activity is related to degree of proteinuria in active puromycin nephrosis (PAN)
28. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
29. The case for intrarenal hypertension in the indication and progression of diabetic and other glomerulopathies
30. Dietary protein intake and progressive nature of kidney disease: the role of hemodynamically mediated injury in the pathogenesis of progressive glomerular sclerosing in aging, renal ablation, and intrinsic renal disease
31. Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis
32. Beneficial effect of angiotensin converting enzyme inhibitor on renal function in patients with diabetic nephropathy